PIP-ENALAPRIL enalapril maleate 5mg tablet blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

enalapril maleate, Quantity: 5 mg

Dostępny od:

GM Pharma International Pty Ltd

INN (International Nazwa):

enalapril maleate

Forma farmaceutyczna:

Tablet

Skład:

Excipient Ingredients: lactose monohydrate; hypromellose; maleic acid; croscarmellose sodium; sodium stearylfumarate

Droga podania:

Oral

Sztuk w opakowaniu:

30

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

HYPERTENSION ,Enalapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. ,CONGESTIVE HEART FAILURE ,Enalapril is indicated for the treatment of all degrees of symptomatic heart failure. In such patients, it is recommended that Enalapril be administered together with a diuretic. ,LEFT VENTRICULAR DYSFUNCTION ,All degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35 percent, irrespective of the presence or severity of obvious symptoms of heart failure.

Podsumowanie produktu:

Visual Identification: White to off white, round, flat faced, beveled edge tablets with breakline on one side and "5" debossed on the other side.; Container Type: Carton; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autoryzacji:

Licence status A

Data autoryzacji:

2013-05-28